FDA 483 - L. Perrigo Company

An FDA inspection of Perrigo Company, PLC, a bio-pharmaceutical analytical facility in Allegan, MI, identified a data integrity concern. The firm was cited for incorrectly transcribing test product slopes in a study report, which led to erroneous calculations of T/R ratios during in vitro release testing. This indicates a breakdown in data accuracy and review processes.